EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hormone and HER2-receptor status in breast cancer: determination using sonographically guided core needle biopsy and correlation with excision specimen—a German single institution diagnostic accuracy study

Maximilian Pruss iD, Jan-Philipp Cieslik, Janet Török, Jerome Dobrowolski, Melissa Neubacher, Martina Helbig, Verena Friebe, Lena Häberle, Natalia Krawczyk, Felix Borgmeier, Tanja Fehm, Frederic Dietzel und 1 weitere

Archives of Gynecology and Obstetrics · 2025

DOI: 10.1007/s00404-024-07920-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Maximilian Pruss und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany. maximili…. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Erb-b2 Receptor Tyrosine Kinases, Receptors, Progesterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sonographically guided core needle biopsy (CNB) is a well-established tool for diagnosing breast lesions. Preoperative estrogen receptor (ER), progesterone receptor (PR), and HER2-receptor status are essential for a personalized treatment approach.

Objectives

We evaluated the concordance of the hormone- and HER2-receptor status between the CNB and the surgical specimen to determine the accuracy of the CNB as a diagnostic method.

Design

This is a non-interventional retrospective study analyzing breast cancer patients treated at the breast care center of the University Medical Center Duesseldorf between January 2002 and December 2005.

Methods

Patients with paired CNB and surgical specimens and a diagnosis of invasive breast cancer were included. ER, PR, and HER2 status were determined by immunohistochemistry (IHC). Patients with IHC 2+ results were further examined by fluorescence in situ hybridization (FISH). Concordance of receptor status was calculated using specificity, sensitivity, and negative and positive predictive values.

Results

We found a very good agreement between CNB and surgical specimens regarding receptor status. A total of 248 patients were analyzed. Concordance rates in cases of primary surgery for ER, PR, and HER2 were 92.9%, 92.9%, and 93%, respectively. In cases of neoadjuvant chemotherapy, the concordance rates for ER, PR, and HER2 were 100%, 87.5%, and 96%, respectively.

Conclusion

CNB demonstrated high diagnostic accuracy compared with surgical specimens regarding ER, PR, and HER2-receptor status. Our findings support the recommendation to use sonographically guided CNB as the initial diagnostic method for guiding tailored treatment plans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenErb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneHumansFemaleMiddle AgedRetrospective StudiesAdultBiopsy, Large-Core NeedleAgedImmunohistochemistryIn Situ Hybridization, FluorescenceAged, 80 and overSensitivity and SpecificityGermanyImage-Guided BiopsyUltrasonography, Interventional

Stichwörter der Autor:innen

Breast cancerConcordance rateCore needle biopsyHER2-receptor statusHormone receptor status

Substanzen

Receptors, EstrogenErb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneERBB2 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany. maximilian.pruss@med.uni-duesseldorf.de.
  • Department of Obstetrics and Gynecology, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Med 360°, Breast Imaging Center of Radiology, Luegallee 52, 40545, Düsseldorf, Germany.
  • Institute of Pathology, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University, 40204, Düsseldorf, Germany.
  • MVZ Amedes for Prenatal-Medicine und Genetic GmbH, 40210, Düsseldorf, Germany.
  • Department of Diagnostic and Interventional Radiology, Medical Faculty, University Duesseldorf, 40225, Duesseldorf, Germany.

ORCID-Profile: Maximilian Pruss

Förderung

  • Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts

Zitieren

APA

Pruss, M., Cieslik, J. P., Török, J., Dobrowolski, J., Neubacher, M., Helbig, M., Friebe, V., Häberle, L., Krawczyk, N., Borgmeier, F., Fehm, T., Dietzel, F., & Mohrmann, S. (2025). Hormone and HER2-receptor status in breast cancer: determination using sonographically guided core needle biopsy and correlation with excision specimen—a German single institution diagnostic accuracy study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07920-5

Vancouver

Pruss M, Cieslik JP, Török J, Dobrowolski J, Neubacher M, Helbig M, et al. Hormone and HER2-receptor status in breast cancer: determination using sonographically guided core needle biopsy and correlation with excision specimen—a German single institution diagnostic accuracy study. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-024-07920-5

BibTeX
@article{Pruss2025,
  author = {Pruss, Maximilian and Cieslik, Jan-Philipp and Török, Janet and Dobrowolski, Jerome and Neubacher, Melissa and Helbig, Martina and Friebe, Verena and Häberle, Lena and Krawczyk, Natalia and Borgmeier, Felix and Fehm, Tanja and Dietzel, Frederic and Mohrmann, Svjetlana},
  title = {Hormone and HER2-receptor status in breast cancer: determination using sonographically guided core needle biopsy and correlation with excision specimen—a German single institution diagnostic accuracy study},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2025},
  doi = {10.1007/s00404-024-07920-5}
}
Kostenlos starten →